University of Houston Secures $3M Grant to Establish Cutting-Edge Cancer Biomarker Facility for Advancing Immunotherapy Research
The University of Houston is at the forefront of advancing cancer research and immunotherapy with its newly established Cancer Immunotherapy Biomarker Core (CIBC), backed by...